Agendia Bv

Contact: Guido Brink
Web: http://www.agendia.com
Address: Kruislaan 406, Amsterdam 1098 SM, Netherlands
Phone: +31-(204)-622315 | Map/Directions >>

Profile: Agendia Bv specializes in breast cancer diagnosis. Our mammaprint provides individualized metastasis risk assessment for breast cancer patients. Our unique 70-gene signature of mammaprint offers unprecedented ability to identify which early-stage breast cancer patients are at the risk of distant recurrence following surgery, independent of estrogen receptor status and any prior treatment.

FDA Registration Number: 3004553686
US Agent: Robin Weiner / Agendia Inc.
Phone: +1-(949)-540-6300 Fax: +1-(949)-472-9500 E-Mail:

1 Products/Services (Click for related suppliers)

• Breast Cancer Rna Gene Expression Recurrence Risk Assessment Prognostic Classifier (FDA Code: NYI / 866.6040)